<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33618">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02668978</url>
  </required_header>
  <id_info>
    <org_study_id>SEALLS</org_study_id>
    <nct_id>NCT02668978</nct_id>
  </id_info>
  <brief_title>SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial Using HEMOPATCH</brief_title>
  <official_title>Prospective Randomized Clinical Trial to Prevent Air Leaks After Lung Resection With Hemopatch™ Sealing Hemostat: SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Quirón Madrid University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter BioScience</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Quirón Madrid University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to assess the efficacy and safety of HEMOPATCH™ Sealing Hemostat in
      reducing the incidence and duration of air leaks after lung resection compared to standard
      techniques.

      Hypothesis: &quot;The routine application of HEMOPATCH Sealing Hemostat on the visceral pleura in
      lung resection areas, during lung resection procedures, is more EFFICIENT to reduce the
      incidence and duration of prolonged air leaks as compared to standard surgical measures.&quot;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of postoperative air leaks</measure>
    <time_frame>Within first 30 postoperative days</time_frame>
    <description>Duration of postoperative lung air leaks expressed in hours</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>LUNG DISEASES</condition>
  <arm_group>
    <arm_group_label>Hemopatch™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hemopatch™ sealing hemostat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard surgical technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hemopatch™ Sealing Hemostat</intervention_name>
    <description>Hemopatch™ application over lung resection areas</description>
    <arm_group_label>Hemopatch™</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard surgical technique</intervention_name>
    <description>Lung resuturing or restapling</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over the age of 18 years who are able to give their informed consent

          -  Patients undergoing lung resection surgery for either malignant or benign conditions
             including:

               -  Lobar and sublobar resections

               -  Open, video-assisted thoracoscopic or robotic surgeries

               -  Diagnostic or therapeutic procedures

        Exclusion Criteria:

          -  Traumatic pulmonary contusion or laceration

          -  Lung reduction surgery

          -  Planned removal of more than 10 lung lesions

          -  Pneumonectomy

          -  Known hypersensitivity to bovine protein

          -  Known hypersensitivity to Brilliant Blue FCF (E133)

          -  Presence of active infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Francisco Javier Moradiellos, MD</last_name>
    <phone>+34606908819</phone>
    <email>dr.moradiellos@cirugiatoracica.es</email>
  </overall_contact>
  <verification_date>January 2016</verification_date>
  <lastchanged_date>January 28, 2016</lastchanged_date>
  <firstreceived_date>January 27, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Quirón Madrid University Hospital</investigator_affiliation>
    <investigator_full_name>Javier MORADIELLOS</investigator_full_name>
    <investigator_title>Associate Chief of Thoracic Surgery</investigator_title>
  </responsible_party>
  <keyword>lung surgery</keyword>
  <keyword>air leak</keyword>
  <keyword>prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
